Exposure of human breast cancer cells to the anti-inflammatory agent indomethacin alters choline phospholipid metabolites and Nm23 expression.

Natarajan, Kshama

Exposure of human breast cancer cells to the anti-inflammatory agent indomethacin alters choline phospholipid metabolites and Nm23 expression. [electronic resource] - Neoplasia (New York, N.Y.) - 409-16 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.

1522-8002

10.1038/sj.neo.7900252 doi


Anti-Inflammatory Agents, Non-Steroidal--pharmacology
Blotting, Western
Breast Neoplasms--drug therapy
Cell Division--drug effects
Choline--metabolism
Cyclooxygenase 1
Cyclooxygenase 2
Epithelial Cells--metabolism
Female
Glycerylphosphorylcholine--metabolism
Humans
Indomethacin--pharmacology
Isoenzymes--metabolism
Magnetic Resonance Spectroscopy
Membrane Proteins
Monomeric GTP-Binding Proteins--metabolism
NM23 Nucleoside Diphosphate Kinases
Nucleoside-Diphosphate Kinase
Phosphorylcholine--metabolism
Prostaglandin-Endoperoxide Synthases--metabolism
Transcription Factors--metabolism
Tumor Cells, Cultured